Therefore, monocytes from melanoma progressively acquire a CD14+/HLA-DR-/low suppressive phenotype that alters T-cell proliferation and interferon-γ production while enhancing the secretion of inhibitory cytokines such as IL-6, TNF-α and TGF-β within the tumor milieu [83–85]. Here, TGFB1 is linked to melanoma.